Rusfertide effective for controlling RBCs overproduction in polycythemia vera: NEJM
USA: A recent multi-centre clinical trial published in the New England Journal of Medicine has shed light on the efficacy and safety of rusfertide, a hepcidin mimetic, in patients with phlebotomy-dependent polycythemia vera. Marina Kremyanskaya, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, and colleagues revealed that in patients with […]